continue to manipulate this stock….now 2
of the GREATEST pRS ever…. Contract with
regeneron and now moderna where each
company GAVE 30 million each to this tiny
under 5.00 company….. this should go way
up even from opening levels of 2.90
Good luck to all
Recent CTMX News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/09/2024 08:06:13 PM
- CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/08/2024 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:08:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:03:47 PM
- CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024 • GlobeNewswire Inc. • 08/01/2024 12:00:00 PM
- CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:35:31 PM
- CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer • GlobeNewswire Inc. • 06/17/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:24:33 PM
- CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/22/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:36:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:36:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:34:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:32:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:31:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:01:57 PM
- CytomX Therapeutics Announces New Employment Inducement Grants • GlobeNewswire Inc. • 05/16/2024 08:15:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/13/2024 08:00:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:41:03 PM
- CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/08/2024 08:10:00 PM
- CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager) • GlobeNewswire Inc. • 05/08/2024 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:04:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:01:21 PM
- CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab) • GlobeNewswire Inc. • 05/07/2024 08:15:00 PM
- CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024 • GlobeNewswire Inc. • 05/01/2024 12:00:00 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM